These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10523583

  • 1. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [Abstract] [Full Text] [Related]

  • 2. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

  • 3. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
    Wieneke CA, Lovrich SD, Callister SM, Jobe DA, Marks JA, Schell RF.
    J Clin Microbiol; 2000 Jan; 38(1):313-7. PubMed ID: 10618107
    [Abstract] [Full Text] [Related]

  • 5. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease.
    Kalish RA, Leong JM, Steere AC.
    Infect Immun; 1995 Jun; 63(6):2228-35. PubMed ID: 7768602
    [Abstract] [Full Text] [Related]

  • 6. Detection of Lyme disease after OspA vaccine.
    Schutzer SE, Luan J, Coyle PK.
    N Engl J Med; 1997 Sep 11; 337(11):794-5. PubMed ID: 9289653
    [No Abstract] [Full Text] [Related]

  • 7. Recommendation to include OspA and OspB in the new immunoblotting criteria for serodiagnosis of Lyme disease.
    Hilton E, Devoti J, Sood S.
    J Clin Microbiol; 1996 Jun 11; 34(6):1353-4. PubMed ID: 8735079
    [Abstract] [Full Text] [Related]

  • 8. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
    Zhong W, Gern L, Kramer M, Wallich R, Simon MM.
    Eur J Immunol; 1997 Nov 11; 27(11):2942-7. PubMed ID: 9394822
    [Abstract] [Full Text] [Related]

  • 9. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.
    Zhang YQ, Mathiesen D, Kolbert CP, Anderson J, Schoen RT, Fikrig E, Persing DH.
    J Clin Microbiol; 1997 Jan 11; 35(1):233-8. PubMed ID: 8968914
    [Abstract] [Full Text] [Related]

  • 10. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ.
    J Clin Microbiol; 2002 Jan 11; 40(1):193-7. PubMed ID: 11773115
    [Abstract] [Full Text] [Related]

  • 11. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
    Wressnigg N, Barrett PN, Pöllabauer EM, O'Rourke M, Portsmouth D, Schwendinger MG, Crowe BA, Livey I, Dvorak T, Schmitt B, Zeitlinger M, Kollaritsch H, Esen M, Kremsner PG, Jelinek T, Aschoff R, Weisser R, Naudts IF, Aichinger G.
    Clin Vaccine Immunol; 2014 Nov 11; 21(11):1490-9. PubMed ID: 25185574
    [Abstract] [Full Text] [Related]

  • 12. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
    Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT.
    J Clin Microbiol; 1999 Dec 11; 37(12):3990-6. PubMed ID: 10565920
    [Abstract] [Full Text] [Related]

  • 13. Early and specific antibody response to OspA in Lyme Disease.
    Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M.
    J Clin Invest; 1994 Jul 11; 94(1):454-7. PubMed ID: 8040289
    [Abstract] [Full Text] [Related]

  • 14. Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.
    Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC.
    Infect Immun; 1997 Mar 11; 65(3):882-9. PubMed ID: 9038292
    [Abstract] [Full Text] [Related]

  • 15. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B, Freer H, Rollins A, Erb HN.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):190-8. PubMed ID: 21208663
    [Abstract] [Full Text] [Related]

  • 16. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
    Kalish RA, Leong JM, Steere AC.
    Infect Immun; 1993 Jul 15; 61(7):2774-9. PubMed ID: 7685738
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
    Schutzer SE, Coyle PK, Krupp LB, Deng Z, Belman AL, Dattwyler R, Luft BJ.
    J Clin Invest; 1997 Aug 15; 100(4):763-7. PubMed ID: 9259573
    [Abstract] [Full Text] [Related]

  • 18. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
    Magnarelli LA, Fikrig E, Padula SJ, Anderson JF, Flavell RA.
    J Clin Microbiol; 1996 Feb 15; 34(2):237-40. PubMed ID: 8788993
    [Abstract] [Full Text] [Related]

  • 19. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis.
    Callister SM, Schell RF.
    J Infect Dis; 1994 Aug 15; 170(2):499-500. PubMed ID: 8035047
    [No Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
    Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.
    Vaccine; 1999 Feb 26; 17(7-8):904-14. PubMed ID: 10067697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.